Skip to main content
Premium Trial:

Request an Annual Quote

Biomax Licenses Protein Prediction Algorithms from Brunak

NEW YORK, Aug. 5 (GenomeWeb News) - Biomax Informatics of Martinsried, Germany,  and Danish firm Brunak Research have signed a collaboration in which Biomax will incorporate protein prediction algorithms into its bioinformatics software, the companies said today.

 

The algorithms, which include SignalP, ChloroP, TargetP, NetPhos, NetOGlyc, NetNGlyc and TMHMM, predict the cellular locations of proteins, as well as their post-translational modifications. They were developed at the Center for Biological Sequence Analysis in Lyngby, Denmark, and Brunak research, which is headquartered in Copenhagen, licenses them out.

 

Academics can already use the protein prediction servers at CBS (http://www.cbs.dtu.dk/services ) free of charge, but commercial users must install the algorithms in-house.

 

Now, the algorithms will be folded into Biomax's Pedant-Pro Sequence Analysis Suite and its ReqALLer Bioinformatics Tool Box, and will be included in the company's human genome database with the option to compare the predictions from these algorithms to results from other algorithms.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.